18F] LBT-999

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	3

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 3 of 3 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04265209 (ClinicalTrials.gov)	December 1, 2021	6/2/2020	[18F] LBT-999PET Compared to [123I]-FP/CIT SPECT to Distinguish Between Parkinson's Diseases and Ess ...	Non-inferiority Study of the Molecular Imaging of Dopamine Transporters Using [123I]-FP/CIT-SPECT an ...	Parkinson Disease;Essential Tremor	Drug: SPECT;Drug: PET	Zionexa	NULL	Recruiting	35 Years	80 Years	All	112	Phase 3	France
2	EUCTR2019-000247-27-FR (EUCTR)	31/03/2021	05/03/2019	Study to demonstrate an at least equivalent performance of a new test in brain imaging test compared ...	Non-inferiority study of the molecular imaging of dopamine transporters using [123I]-FP/CIT-SPECT an ...	Patients suffering from an essential tremor or with Parkinson's disease. MedDRA version: 20.0;Level: ...	Trade Name: DaTSCAN 74 MBq/ml solution for injection Product Code: [18F] LBT-999	ZIONEXA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	112	Phase 3	France
3	NCT02393027 (ClinicalTrials.gov)	March 2015	6/3/2015	Quantification of Dopamine Active Transporter (DAT) in Humans: Validation of a New Radiophamaceutica ...	Quantification of Dopamine Active Transporter (DAT) in Humans: Validation of a New Radiophamaceutica ...	Idiopathic Parkinson Disease	Drug: [18F] LBT-999 PET	University Hospital, Tours	NULL	Terminated	45 Years	75 Years	All	16	Early Phase 1	France

First Previous1Next Last